Research and Clinical Trials

A clinical research study is also called a clinical trial. Each study tests the safety, effectiveness, and side effects of an investigational medicine(s) or an investigational device on a group of volunteers. Clinical research studies are an important step in making new investigational medications available for future use.

Every day, research uncovers new information about diseases and their treatment. By taking part in a clinical research study, you are an important link in a long chain of research and testing of new investigational medicines for future use.

With decades of experience as pulmonologists and investigators, we know that patients — particularly those with COPD — are interested in receiving closer care. In other words, they desire more hands-on time with the specialist, which is a key motivator for patients to participate in clinical trials. This is particularly the case for patients who are still struggling with their illness despite treatment.

Patients considering participation in COPD studies also benefit simply from the screening process. Regardless of whether they are chosen for the study, they receive a “snapshot” of their lung function (spirometry) at no cost.

Other motivators include:

• Greater frequency of specialty tests and exams
• Zero-cost medications and care
• Priority visits
• Reimbursement for time and expenses
• Potential for effective relief that has otherwise been elusive

COPD

Today, most pharmaceutical companies that are researching new treatments desire a particular type of COPD patient. For starters, because age is an important factor in the incidence of COPD, patients must be age 40 or older in order to be eligible. A personal history of smoking is also a key eligibility factor, and the ideal candidate is a COPD patient who has a history of one or more packs per day for 10 or more years.

Asthma

If you are 18 years of age or older you may be eligible for a study. Typically, patients with an extensive smoking history are not eligible.